Physician profile

Jeffrey A Cohen

Neurology (Psychiatry & Neurology) · Lebanon, NH

NPI 1457319667

$17,589.35

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

See the full distribution for Neurology (Psychiatry & Neurology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$13,000.00
Honoraria$4,500.00
Food and Beverage$89.35

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sarepta Therapeutics, INC. $7,000.00 2023
Eisai INC. $6,000.00 2023
H. Lundbeck A S $4,500.00 2023
Takeda Pharmaceuticals U.S.A., INC. $61.27 2023-2024 Hyqvia, Gammagard
Inari Medical, INC. $28.08 2023 Flowtriever Catheter, S, Ct Thrombectomy System Kit

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jeffrey A Cohen

$17,589.35

in general payments reported 2019-2025

Years
2023-2024
Top company
Sarepta Therapeutics, INC.

https://glasscript.com/doctor/1002647/jeffrey-a-cohen

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.